How much evidence is needed before additional testing is incentivised at scale?
Open Access
- 1 October 2026
- journal article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 76 (771) , 441-443
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Evidence-based blood tests for monitoring adults with chronic kidney disease stage G3 in primary care: rapid review, routine data analysis, and consensus studyThe Lancet Primary Care, 2026
- General practice incentives: a review of the international literatureBritish Journal of General Practice, 2025
- Evidence-based tests to monitor adults with type 2 diabetes mellitus in primary care: rapid reviews and consensus processBritish Journal of General Practice, 2025
- Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort studyThe Lancet Diabetes & Endocrinology, 2022
- Are guidelines for monitoring chronic disease in primary care evidence based?BMJ, 2019
- Choosing Wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicineBMJ, 2015
- Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practicesImplementation Science, 2014
- Normal diagnostic test results do not reassure patientsBMJ Evidence-Based Medicine, 2013
- Preventing overdiagnosis: how to stop harming the healthyBMJ, 2012
- Cascade Effects of Medical TechnologyAnnual Review of Public Health, 2002